Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
7
×
glaxosmithkline
7
×
life sciences
national blog main
national top stories
startups
biotech
boston blog main
boston top stories
san francisco blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
alzheimer's disease
amgen
biogen
bristol-myers squibb
cancer
cancer immunotherapy
drug prices
eli lilly
generic drugs
What
bio
roundup
drug
new
adds
alliance
crispr
disease
earlier
medicines
million
acquire
acquisition
acquisitions
address
ago
albert
allosteric
appetite
approval
areas
biggest
biogen’s
biopharmaceutical
biosciences
bio’s
black
boosts
bourla
bread
brii
bristol
butter
buy
buyout
calls
cancer
cash
ceo
changing
Language
unset
unknown
Current search:
glaxosmithkline
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal